Issue 37, 2018

2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design

Abstract

2,3-Dihydroquinazolin-4-one (DHQ) belongs to the class of nitrogen-containing heterocyclic compounds representing a core structural component in various biologically active compounds. In the past decades, several methodologies have been developed for the synthesis of the DHQ framework, especially the 2-substituted derivatives. Unfortunately, multistep syntheses, harsh reaction conditions, and the use of toxic reagents and solvents have limited their full potential as a versatile fragment. Recently, use of green chemistry and alternative strategies are being explored to prepare diverse DHQ derivatives. This fragment is used as a synthon for the preparation of biologically active quinazolinones and as a functional substrate for the synthesis of modified DHQ derivatives exhibiting different biological properties. In this review, we provide a comprehensive assessment of the synthesis and biological evaluations of DHQ derivatives.

Graphical abstract: 2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design

Article information

Article type
Review Article
Submitted
02 Apr 2018
Accepted
29 May 2018
First published
07 Jun 2018
This article is Open Access
Creative Commons BY license

RSC Adv., 2018,8, 20894-20921

2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design

M. Badolato, F. Aiello and N. Neamati, RSC Adv., 2018, 8, 20894 DOI: 10.1039/C8RA02827C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements